Clinical Trials in Illinois

Showing 181-200 of 9,411 trials

Mucopolysaccharidosis VII Disease Monitoring Program

NCT03604835

The objectives of this study are to characterize MPS VII disease presentation and progression and assess long-term effectiveness and safety, including hypersensitivity reactions and immunogenicity of vestronidase alfa.

Mucopolysaccharidosis VIIMPS VIIMPS 7+1 more

Ultragenyx Pharmaceutical Inc50 participantsStarted Jan 2018

Orange, California, United States • Washington D.C., District of Columbia, United States • Chicago, Illinois, United States +11 more locations

RECRUITINGPHASE3125 miles

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

NCT04786262

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.

Diabetes Mellitus, Type 1Impaired Hypoglycemic AwarenessSevere Hypoglycemia

Vertex Pharmaceuticals Incorporated52 participantsStarted Mar 2021

Duarte, California, United States • San Francisco, California, United States • Miami, Florida, United States +26 more locations

Mucopolysaccharidosis VII Disease Monitoring Program

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Find Trials by Condition in Illinois

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

ELEVATE High-Risk PCI Pivotal Study

A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

Evolut™ EXPAND TAVR II Pivotal Trial

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Empathic Communication Skills (ECS) Training

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging

AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

A Randomized, Active-Controlled, Double-Masked, Crossover Study to Evaluate the Clinical Performance of Deseyne (Vifilcon C) Daily Disposable Soft Contact Lens for Presbyopia Extended Depth of Focus (EDOF)